Lyon, France, and Odense, Denmark; May 9, 2023: Today at AOHUPO in Singapore, Cellenion is pleased to announce a new co-marketing partnership with Evosep. This partnership will enable. | May 10, 2023
Evosep today announced that Novo Holdings A/S has become a minority shareholder in Evosep Aps with a US$ 40m investment to further Evosep’s technology and application portfolio for clinical proteomics.
COPENHAGEN, Denmark, Jan. 9, 2023 /PRNewswire/ Novo Holdings, a leading international life science investor, today announced a $40m investment in Evosep, the bioscience company leading the